Francesca Poggio

6PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.

Benedetta Conte, Luca Boni, Giancarlo Bisagni

|Oct 25, 2023
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis

|Dec 01, 2021
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.

Matteo Lambertini, Luca Boni, Andrea Michelotti

|Aug 21, 2020
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study.

Eva Blondeaux, Arlindo R Ferreira, Francesca Poggio

|Aug 09, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.

Francesca Poggio, Matteo Lambertini, Claudia Bighin

Pageof 1

Frequent Collaborators

5 joint publications

Matteo Lambertini

3 joint publications

Lucia Del Mastro

2 joint publications

Fabio Puglisi

2 joint publications

Luca Boni